Kamada to support and participate in Immunology of Diabetes Society (IDS)

Kamada is proud to be one of the supporting partners of the upcoming  IDS congress.

The congress will include  talks on a wide range of current topics of interest to the community, which include ground-breaking technologies, cell-based and advanced therapeutics, immunopathology of type 1 diabetes, pathways to beta cell failure, updates from the Networks – nPod, TEDDY, Trialnet and the Immune Tolerance Network, as well as an adversarial debate and a “balloon debate”. There will be ample opportunities for networking and discussion, to move towards our common goal of understanding the immunology of type 1 diabetes and how we may intervene to change the course of disease.

https://ids2018.org/en/sponsors/sponsor/detail/6/kamada-biopharmaceuticals